Amir Fathi, MD

Articles by Amir Fathi, MD

Considerations for Patient Monitoring Following CAR T and Bispecific Administration: Amir Fathi, MD

August 14th 2025

Amir Fathi, MD, leukemia specialist at Massachusetts General Hospital, discusses the importance of advocacy by both patients and their treatment team and key distinct toxicities that require vigilance.

Expertise Is Essential to Bispecific Access for Patients With Acute Leukemias: Amir Fathi, MD

ByMaggie L. Shaw,Amir Fathi, MD

July 23rd 2025

Amir Fathi, MD, discusses one of the biggest nonfinancial barriers to bispecific therapies: the expertise required to safely administer and manage them.

Amir Fathi, MD

Articles by Amir Fathi, MD

Considerations for Patient Monitoring Following CAR T and Bispecific Administration: Amir Fathi, MD

Expertise Is Essential to Bispecific Access for Patients With Acute Leukemias: Amir Fathi, MD

Latest Updated Articles

Trending on AJMC

Government Shutdown Could Disrupt Health Care Access

Most Medicare Beneficiaries Find Plan Shopping Confusing, Survey Finds

Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries

Lurbinectedin Combo Approved by FDA for Extensive-Stage Small Cell Lung Cancer

Rheumatoid Arthritis Linked to Elevated Pneumonia Risk, Especially in Seropositive Disease